<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transplantation of hematopoetic stem cells is established therapy today </plain></SENT>
<SENT sid="1" pm="."><plain>It includes transplants from bone marrow, peripheral blood or cord blood </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001909'>Leukemias</z:hpo>, <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disorders</z:e> of the bone marrow are main indications for allogeneic, <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo>, <z:hpo ids='HP_0001909'>leukemias</z:hpo>, <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> and severe <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> main indications for autologous transplants </plain></SENT>
<SENT sid="3" pm="."><plain>New developments, such as reduced intensity conditioning approaches and selective donor lymphocyte infusions open the procedure to older patients and to those with coexisting other morbidities </plain></SENT>
<SENT sid="4" pm="."><plain>Whenever possible, the transplant is integrated into the treatment plan from diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>The individual risk profile determines choice of procedure and time point </plain></SENT>
<SENT sid="6" pm="."><plain>Diagnosis and age as sole criteria no longer suffice </plain></SENT>
<SENT sid="7" pm="."><plain>Hematopoetic stem cell transplantation might serve in the future as a model for stem cell transplants for other organs </plain></SENT>
</text></document>